2018-09-01 Bio Spectrum

REGULARS

BioEdit ....................................................................... 06

BioMail ...................................................................... 08

Policy and Regulatory News .................................... 09

Finance News ............................................................ 12

Company News ......................................................... 14

Start-up News ........................................................... 16

World News ............................................................... 18

Supplier News ........................................................... 40

People News ............................................................. 42

Science News............................................................ 45

Academic News ........................................................ 48

BioEvent .................................................................... 49

TOPVIDEO

BIOSPECTRUM | SEPTEMBER 2018 | http://www.biospectrumindia.com BIO CONTENT^5

Subith, CEO,

Duraent Life

Sciences

discusses India’s

hold and growth in

the global organ

transplantation

market.

Scan the QR Code »

Prof K

VijayRaghavan,

Principal Scientific

Advisor to the

Government,

points out the

shortcomings

of the regulatory

system for

startups in India.

Scan the QR Code »

Dr Renu Swarup,

Secretary, DBT

talks about the

new programmes

government is

developing in

order to ease

out the path for

innovators.

Scan the QR Code »

TECHNOLOGIES

31

India

supporting

development

of myo–

prosthetics

Peter Farrell,

Executive Vice President, Worldwide

Commercial Operations, Cepheid

Jai Shankar Krishnan,

President and CEO, India and

Southeast Asia, Danaher

Q&A

34

“Training of doctors today

is a major issue worldwide”

Dr Ashish V. Rawandale-Patil,

Director, Tejnaksh Healthcare

36

‘‘Ferring will continue to launch the

global research products in India”

Suresh Pattathil,

Chief Executive Officer (CEO),

India, Ferring Pharmaceuticals

38

“We support India’s target of TB elimination by 2025”